# Corvus Pharmaceuticals, Inc.: Form SC 13D/A, filed May 8, 2024

- Company: [Corvus Pharmaceuticals, Inc.](/companies/crvs.md) (CIK 1626971)
- Form: SC 13D/A
- Filed: 2024-05-08
- Accepted by EDGAR: May 8, 2024, 19:55 ET
- Period: not reported
- Accession: 0000947871-24-000449
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1626971/000094787124000449/ss3362183_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1626971/000094787124000449/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1626971/000094787124000449/ss3362183_sc13da.htm

Filed May 8, 2024.
Source: SEC EDGAR, the filing index for accession 0000947871-24-000449. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.